Advanced Search

Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 1999 March;45(1) > Minerva Gastroenterologica e Dietologica 1999 March;45(1):59-76



A Journal on Gastroenterology, Nutrition and Dietetics

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

Frequency: Quarterly

ISSN 1121-421X

Online ISSN 1827-1642


Minerva Gastroenterologica e Dietologica 1999 March;45(1):59-76


Topical beclomethasone dipropionate (BDP) in intestinal inflammatory diseases: the results of a multicentre trial

Borzio M., Borzio F., Milano G., Biraghi M., Cestari L., Ravelli P., de Franchis R., Vecchi M., Minoli G., Prada A., Curzio M., Galeone M., Toti G. L., Cacioli D., Megevand J.

The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.

language: Italian

Full text temporarily not available online. Contact us  REPRINTS

top of page